Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Jenner Institute Newsletter - Autumn 2016

Aedes aegypti - mosquito vector of zika, chikungunya and rift valley fever.

HIGHLIGHTS

IN THIS ISSUE

1. New Jenner Vaccine programmes: Zika, Chikungunya, Rift Valley Fever and MERS

2. Vaccitech: Spinout kick-starts with £10m from Oxford Sciences Innovation

3. Ebola outbreak: Four vaccines assessed in Oxford in six months

4. Making vaccines work in the liver

5. Development of a therapeutic vaccine against cervical pre-cancer

6. Developing a vaccine to prevent Hepatitis C infection

7. Improving FMD vaccine production and supply

8. UK Veterinary Vaccinology Network

9. About the Jenner Institute

10. New Jenner Investigators

11. Vaccinology in Africa Master's Level Course, April 2017, Entebbe, Uganda